Search results
Results from the WOW.Com Content Network
They discovered that patients who were prescribed semaglutide (the active ingredient in Ozempic and Wegovy) had a "significantly" lower risk of developing Alzheimer’s disease compared to people ...
A recent study found that a class of medications called SGLT-2 inhibitors—which does not include Ozempic or similar drugs like Zepbound—significantly lowered the risk of dementia in people ...
According to recent research, semaglutide drugs, such as Ozempic and Wegovy, are linked to a lower risk of cognitive problems, as well as reduced cravings for nicotine.
“About 20% of my patients will discontinue use as they have difficulty tolerating Ozempic due to these side effects,” says Florence Comite, M.D., founder of the Comite Center for Precision ...
If you’ve been taking Ozempic, Wegovy, ... A Novo Nordisk-funded 2021 study looked at almost 2,000 adults with excess body weight or obesity without diabetes. Participants took once-weekly 2.4 ...
You may have heard about — or maybe even experienced — the short-term side effects of Ozempic® — such as nausea, vomiting, constipation, and diarrhea. But what about its long-term effects?
“About 20% of my patients will discontinue use as they have difficulty tolerating Ozempic due to these side effects,” says Florence Comite, M.D., founder of the Comite Center for Precision ...
According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy, and ...